Rhumbline Advisers Horizon Therapeutics Public LTD CO Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$98.98 - $115.74 $427,098 - $499,418	-4,315 Reduced 1.39%	306,817 $35.5 Million
Q2 2023 Aug 08, 2023	BUY	$96.34 - $112.38 $3.63 Million - $4.23 Million	37,657 Added 13.77%	311,132 $32 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $1.83 Million - $1.94 Million	17,073 Added 6.66%	273,475 $29.8 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $426,872 - $778,619	6,842 Added 2.74%	256,402 $29.2 Million
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $883,800 - $1.27 Million	15,000 Added 6.39%	249,560 $15.4 Million
Q2 2022 Aug 11, 2022	BUY	$79.4 - $116.36 $3.07 Million - $4.5 Million	38,672 Added 19.74%	234,560 $18.7 Million
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $223,482 - $283,968	-2,586 Reduced 1.3%	195,888 $20.6 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $393,648 - $478,920	3,994 Added 2.05%	198,474 $21.4 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $1.33 Million - $1.59 Million	-14,439 Reduced 6.91%	194,480 $21.3 Million
Q2 2021 Aug 05, 2021	SELL	$86.24 - $95.92 $641,280 - $713,261	-7,436 Reduced 3.44%	208,919 $19.6 Million
Q1 2021 May 06, 2021	SELL	$71.83 - $95.48 $843,715 - $1.12 Million	-11,746 Reduced 5.15%	216,355 $19.9 Million
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $74,370 - $93,672	-1,110 Reduced 0.48%	228,101 $16.7 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $128,078 - $185,357	2,319 Added 1.02%	229,211 $17.8 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $98,663 - $186,153	3,267 Added 1.46%	226,892 $12.6 Million
Q1 2020 May 06, 2020	BUY	$24.87 - $38.56 $961,722 - $1.49 Million	38,670 Added 20.91%	223,625 $6.62 Million
Q4 2019 Feb 05, 2020	BUY	$25.43 - $36.67 $88,954 - $128,271	3,498 Added 1.93%	184,955 $6.7 Million
Q3 2019 Oct 23, 2019	SELL	$23.0 - $27.97 $193,200 - $234,948	-8,400 Reduced 4.42%	181,457 $4.94 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $4.33 Million - $5.41 Million	189,857 New	189,857 $4.57 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account